Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
15.37
-0.08 (-0.52%)
At close: Dec 2, 2025, 4:00 PM EST
15.20
-0.17 (-1.11%)
After-hours: Dec 2, 2025, 6:52 PM EST
Eton Pharmaceuticals Employees
Eton Pharmaceuticals had 31 employees as of December 31, 2024. The number of employees increased by 1 or 3.33% compared to the previous year.
Employees
31
Change (1Y)
1
Growth (1Y)
3.33%
Revenue / Employee
$2,268,258
Profits / Employee
-$215,548
Market Cap
412.19M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31 | 1 | 3.33% |
| Dec 31, 2023 | 30 | 2 | 7.14% |
| Dec 31, 2022 | 28 | 11 | 64.71% |
| Dec 31, 2021 | 17 | 1 | 6.25% |
| Dec 31, 2020 | 16 | -1 | -5.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ETON News
- 8 days ago - Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th - GlobeNewsWire
- 20 days ago - Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th - GlobeNewsWire
- 26 days ago - Eton Pharmaceuticals, Inc. (ETON) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - GlobeNewsWire
- 3 months ago - Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference - GlobeNewsWire
- 4 months ago - Eton Pharmaceuticals, Inc. (ETON) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options - Seeking Alpha